📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Memory Pharmaceuticals

1.1 - Company Overview

Memory Pharmaceuticals Logo

Memory Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical discovery and development of drug candidates for central nervous system conditions, including neurological diseases associated with aging (such as Alzheimer's disease) and psychiatric disorders such as schizophrenia.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Memory Pharmaceuticals

Reunion Neuroscience Logo

Reunion Neuroscience

HQ: Canada Website
  • Description: Provider of clinical-stage therapeutic solutions for underserved mental health conditions, developing RE104, a proprietary short-duration serotonergic psychedelic therapy for postpartum depression and other mental health disorders, and RE200s, discovery candidates structurally similar to classic psychedelics designed to selectively target the serotonin 2A receptor without off-target effects.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Reunion Neuroscience company profile →
Torrey Pines Therapeutics Logo

Torrey Pines Therapeutics

HQ: United States Website
  • Description: Provider of small molecule drug discovery and development in the United States, with a portfolio comprising candidates from proprietary drug-targeting platforms and in-licensed/acquired programs. As of August 31, 2010, the company's pipeline includes three clinical development programs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Torrey Pines Therapeutics company profile →
Quoin Pharmaceuticals Logo

Quoin Pharmaceuticals

HQ: United States Website
  • Description: Provider of pharmaceutical products under development addressing major unmet medical needs, including QRX003, a topical lotion in clinical evaluation for Netherton Syndrome, Peeling Skin Syndrome, SAM Syndrome, and Palmoplantar Keratoderma; QRX008 for Scleroderma; QRX007 for Netherton Syndrome; and QRX004 for Epidermolysis Bullosa.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Quoin Pharmaceuticals company profile →
Supernus Pharmaceuticals Logo

Supernus Pharmaceuticals

HQ: United States Website
  • Description: Provider of specialty pharmaceutical products for central nervous system diseases, developing and commercializing therapies including Qelbree for ADHD; Trokendi XR for epilepsy and migraine prevention; and Oxtellar XR for epilepsy, with pipeline candidates SPN-830 for hypomobility in Parkinson’s disease, SPN-820/821 for treatment-resistant depression, and SPN-817 for severe epilepsy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Supernus Pharmaceuticals company profile →
SyntheticMR Logo

SyntheticMR

HQ: Sweden Website
  • Description: Provider of innovative magnetic resonance imaging software that supports shorter exam times and delivers more information to clinicians. Products include SyMRI NEURO for quantitative MRI with contrast images, tissue segmentation, and volumetric measurements in a single scan; SyMRI MSK for musculoskeletal imaging with quantitative maps and contrast images; and MAGiC, a GE Healthcare version offering customizable MRI imaging solutions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SyntheticMR company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Memory Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Memory Pharmaceuticals

2.2 - Growth funds investing in similar companies to Memory Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Memory Pharmaceuticals

4.2 - Public trading comparable groups for Memory Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Memory Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Memory Pharmaceuticals

What does Memory Pharmaceuticals do?

Memory Pharmaceuticals is a provider of biopharmaceutical discovery and development of drug candidates for central nervous system conditions, including neurological diseases associated with aging (such as Alzheimer's disease) and psychiatric disorders such as schizophrenia.

Who are Memory Pharmaceuticals's competitors?

Memory Pharmaceuticals's competitors and similar companies include Reunion Neuroscience, Torrey Pines Therapeutics, Quoin Pharmaceuticals, Supernus Pharmaceuticals, and SyntheticMR.

Where is Memory Pharmaceuticals headquartered?

Memory Pharmaceuticals is headquartered in United States.

How many employees does Memory Pharmaceuticals have?

Memory Pharmaceuticals has 1,000 employees 🔒.

When was Memory Pharmaceuticals founded?

Memory Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Memory Pharmaceuticals in?

Memory Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Memory Pharmaceuticals

Who are the top strategic acquirers in Memory Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Memory Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Memory Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Memory Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Memory Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Memory Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Memory Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Memory Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Memory Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Memory Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Memory Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Memory Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Memory Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Memory Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Memory Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Memory Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Memory Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Memory Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Memory Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Memory Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Memory Pharmaceuticals

Launch login modal Launch register modal